Contineum Therapeutics annual operating margin
2023
Contineum Therapeutics's operating margin was 32.15% for fiscal 2023.
View full Contineum Therapeutics company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2023 | 2023-12-31 | 32.15% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2023 | 2023-06-30 | 77.87% | — |
The latest reported quarter, Q2 2023, shows 77.87%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Contineum Therapeutics source filings ↗